Press Release: Rexahn : Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
Merger completed with Rexahn Pharmaceuticals creating a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphires Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading...
Read full article »
Rexahn is a clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Read more